Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 043704/0578 | |
| Pages: | 11 |
| | Recorded: | 09/26/2017 | | |
| Attorney Dkt #: | 4239-99180-51 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/2020
|
Application #:
|
15710672
|
Filing Dt:
|
09/20/2017
|
|
Publication #:
|
|
Pub Dt:
|
01/11/2018
| | | | |
|
Title:
|
DENGUE TETRAVALENT VACCINE CONTAINING A COMMON 30 NUCLEOTIDE DELETION IN THE 3'-UTR OF DENGUE TYPES 1, 2, 3, AND 4, OR ANTIGENIC CHIMERIC DENGUE VIRUSES 1, 2, 3, AND 4
|
|
|
Assignee
|
|
|
|
|
| 6011 EXECUTIVE BOULEVARD |
| SUITE 325, MSC 7660 |
| BETHESDA, MARYLAND 20892-7660 |
|
|
Correspondence name and address
|
| |
GREGORY SCOTT, KLARQUIST SPARKMAN, LLP
|
| |
121 SW SALMON STREET
|
| |
SUITE 1600
|
| |
PORTLAND, OR 97204
|
Search Results as of:
04/26/2024 02:56 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
